Published September 28, 2018
Biocon Limited (BIOCON.NS) Close: 708.40
An approximate horizontal trend channel in the medium term is broken up. Trading inside a more neutral zone between 675 and 553 since January 2018, finally BIOCON has broken out from it and has initiated a new buy signal. Continued strong development is indicated. There is support around 640 rupees and further around 570-553 on a medium to longer term perspective.
Biocon Limited has more than doubled in the last one year and is in a rising trend channel in the long term chart. This rise has been supported by higher volume on price rise and lower volume on reactions, as indicated by positive volume balance. Also the momentum in the stock is positive, strengthening the increase in price. The stock is overall assessed as technically positive for the medium to long term.
Investtech’s outlook one to six quarters: Positive
Investtech's recommendation: Buy
The analysis is based on closing price as per September 27, 2018.
Investeringsanbefalinge(r)n(e) er udarbejdet af Investtech.com AS ("Investtech"). Investtech garanterer ikke for fuldstændigheden eller rigtigheden af analysen. Eventuel eksponering i forhold til de råd / signaler, som fremkommer i analyserne, står helt og holdent for investors regning og risiko. Investtech er hverken direkte eller indirekte ansvarlig for tab, der opstår som følge af brug af Investtechs analyser. Oplysninger om eventuelle interessekonflikter vil altid fremgå af investeringsanbefalingen. Yderligere information om Investtechs analyser findes på infosiden.
Investeringsanbefalinge(r)n(e) er udarbejdet af Investtech.com AS ("Investtech"). Investtech garanterer ikke for fuldstændigheden eller rigtigheden af analysen. Eventuel eksponering i forhold til de råd / signaler, som fremkommer i analyserne, står helt og holdent for investors regning og risiko. Investtech er hverken direkte eller indirekte ansvarlig for tab, der opstår som følge af brug af Investtechs analyser. Oplysninger om eventuelle interessekonflikter vil altid fremgå af investeringsanbefalingen. Yderligere information om Investtechs analyser findes på infosiden.